Bellevue Group Ag Viatris Inc Transaction History

Bellevue Group Ag

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.32 - $12.13 $131,600 - $154,681	12,752 Added 48.06%	39,283 $456,000
Q2 2024 Aug 14, 2024	BUY	$10.05 - $12.02 $120,760 - $144,432	12,016 Added 82.78%	26,531 $282,000
Q1 2024 May 15, 2024	SELL	$11.27 - $13.53 $39,309 - $47,192	-3,488 Reduced 19.37%	14,515 $173,000
Q4 2023 Feb 14, 2024	SELL	$8.77 - $10.85 $1.39 Million - $1.72 Million	-158,845 Reduced 89.82%	18,003 $194,000
Q3 2023 Nov 14, 2023	BUY	$9.59 - $11.35 $1.7 Million - $2.01 Million	176,848 New	176,848 $1.74 Million
Q1 2021 May 12, 2021	SELL	$13.59 - $18.54 $124,606 - $169,993	-9,169 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $131,116 - $171,827	9,169 New	9,169 $172,000

1,141

988M

2.34M

2.21M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $11.5B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

Stay updated on Bellevue Group Ag with notifications on news.